Trial Profile
Characteristics of Treatment Responders to Galantamine Administration in the Patients With Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2016
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 28 Apr 2011 New trial record